Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2720]
News [7073]
Articles [272]
Editorials [8]
Conferences [215]
elearning [41]
Early stage trials in immunotherapy and brain screening
Dr Elena Garralda - Vall d'Hebron Institute of Oncology, Barcelona, Spain
Early stage trials in immunotherapy and brain screening ( Dr Elena Garralda - Vall d'Hebron Institute of Oncology, Barcelona, Spain )
20 Oct 2018
Alpelisib and fulvestrant for advanced breast cancer: SOLAR-1
Prof Fabrice André - Institut Gustave Roussy, Paris, France
Alpelisib and fulvestrant for advanced breast cancer: SOLAR-1 ( Prof Fabrice André - Institut Gustave Roussy, Paris, France )
20 Oct 2018
Results from the IMpassion130 trial for triple-negative breast cancer
Prof Peter Schmid - St Bartholomew Hospital London, UK
Results from the IMpassion130 trial for triple-negative breast cancer ( Prof Peter Schmid - St Bartholomew Hospital London, UK )
20 Oct 2018
PALOMA-3 update, including OS data for HR positive HER2 negative breast cancer
Prof Massimo Cristofanilli - Feinberg School of Medicine, Chicago, USA
PALOMA-3 update, including OS data for HR positive HER2 negative breast cancer ( Prof Massimo Cristofanilli - Feinberg School of Medicine, Chicago, USA )
20 Oct 2018
Results from the PALOMA-3 trial for advanced breast cancer
Prof Massimo Cristofanilli - Feinberg School of Medicine, Chicago, USA
Results from the PALOMA-3 trial for advanced breast cancer ( Prof Massimo Cristofanilli - Feinberg School of Medicine, Chicago, USA )
20 Oct 2018
Immunological monitoring of patients receiving immunotherapy
Prof Jaques van Dongen - Leiden University, Netherlands
Immunological monitoring of patients receiving immunotherapy ( Prof Jaques van Dongen - Leiden University, Netherlands )
18 Oct 2018
Combining MRD quantitation and genetics in post-remission risk stratification
Dr John Moppett - University Hospitals Bristol NHS Foundation Trust, Bristol, UK
Combining MRD quantitation and genetics in post-remission risk stratification ( Dr John Moppett - University Hospitals Bristol NHS Foundation Trust, Bristol, UK )
18 Oct 2018
Management of MLL-rearranged ALL
Prof Rob Pieters - Princess Maxima Centre for paediatric oncology (UU), Utrecht...
Management of MLL-rearranged ALL ( Prof Rob Pieters - Princess Maxima Centre for paediatric oncology (UU), Utrecht, Netherlands )
18 Oct 2018
Editor’s Choice for September 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor’s Choice for September 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
28 Sep 2018
The microbiome – a novel paradigm in oncology research
Dr Alasdair Scott - Imperial College London, London, UK
The microbiome – a novel paradigm in oncology research ( Dr Alasdair Scott - Imperial College London, London, UK )
5 Sep 2018
Editor's Choice for August 2018
Prof Gordon McVie - Founding Editor, ecancer
Editor's Choice for August 2018 ( Prof Gordon McVie - Founding Editor, ecancer )
22 Aug 2018
Updates from a range of lung cancer studies
Prof Edgardo S. Santos - Lynn Cancer Institute, Boca Raton, USA
Updates from a range of lung cancer studies ( Prof Edgardo S. Santos - Lynn Cancer Institute, Boca Raton, USA )
7 Aug 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation